Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Wei

tD33NAt

Active member
Joined
Mar 24, 2008
Messages
12,519
Reaction score
0
Points
36
The addition of the highly selective, once-daily dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin (Januvia), compared with glimepiride (Amaryl), to background metformin therapy provides similar glycemic control in type 2 diabetics but, importantly, produces significantly fewer hypoglycemic episodes and also results in weight loss, new data show. The findings were announced at the 46th European Association for the Study of Diabetes (EASD) meeting...


orpIutcM-m8


More...
 
Back
Top